Pharmaceutical Raw Material Identification

The analysis of all incoming pharmaceutical raw materials is a key part of GMP compliance to guarantee safety and efficacy of a finished dosage form which is largely dependent on the purity and quality of the bulk active drug substance and excipient.

The drug substance manufacturer must have complete knowledge of the manufacturing process and the potential impurities that may appear in the drug substance and excipient. It is therefore important to have a high-throughput method by which raw materials may be analysed in a loading bay or warehouse, while also preventing sample exposure to avoid contamination.

The suitability of drug substance for its intended use is defined by attributes such as identity, strength, and purity – which can be achieved by using our instruments, consumables, and services.